A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted wirelessly to a smartphone. To ensure that the data is accurate, an accelerometer within the smartphone is used to measure movement of the smartphone and/or the user. Once accurate data is acquired, it is uploaded to the cloud (or host), where the data is used (alone or together with other vital signs) to determine whether the user is suffering from (or likely to suffer from) a viral infection, such as COVID-19. Depending on the specific requirements, the data, changes thereto, and/or the determination can be used to alert medical staff and take corresponding actions.
Sources:
- September 3, 2020. Richard A. ROTHSCHILD. System and Method for Testing for COVID-19. United States US20200279585A1, filed May 17, 2020, and issued September 3, 2020.
https://patents.google.com/patent/US20200279585A1,
Local copy.
Patent. - June 1, 2021. Richard A. Rothschild. System and method for testing for COVID-19. United States US11024339B2, filed May 17, 2020, and issued June 1, 2021.
https://patents.google.com/patent/US11024339B2,
Local copy.
Patent. - October 29, 2020. Silviu “Silview” Costinescu. “Why Did the Rothschilds Patent COVID-19 Biometric Tests in 2015 and 2017?” State of the Nation.
http://stateofthenation.co/?p=33959.
News.
Related:
- “Richard Rothschild.” Facebook.
https://www.facebook.com/richard.rothschild.522.
Social Media.
See also, on this site:
- Richard Rothschild and others file patent 10242713: System and method for using, processing, and displaying biometric data
- Patent 11107588: Methods and systems of prioritizing treatments, vaccination, testing and/or activities while protecting the privacy of individuals
